Overview

New Methods for Evaluating Preventive Migraine Treatment

Status:
RECRUITING
Trial end date:
2028-09-01
Target enrollment:
Participant gender:
Summary
The study aims to estimate treatment effects in a balanced placebo design (BPD) to specify to which extent contextual factors interact in preventive migraine treatment and influence adverse event occurrence in patients with chronic migraine. Using a clinical within-subjects design, patients with chronic migraine will receive four treatment conditions in a randomized order.
Phase:
NA
Details
Lead Sponsor:
University of Aarhus